Ok Biotech Co Ltd (4155) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, Ok Biotech Co Ltd (4155) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$47.74 Million ≈ $1.50 Million USD) by net assets (NT$2.52 Billion ≈ $79.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Ok Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Ok Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 4155 current and long-term liabilities for a breakdown of total debt and financial obligations.

Ok Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ok Biotech Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sirios Resources Inc. V:SOI	-0.045x
Where Food Comes From Inc NASDAQ:WFCF	0.049x
Greatland Resources Limited LSE:GGP	0.460x
Dongwon Metal KO:018500	0.094x
RBZ Jewellers Limited NSE:RBZJEWEL	N/A
Iskandar Waterfront City Bhd KLSE:1589	0.015x
Awale Resources Ltd V:ARIC	-0.027x
Adveritas Ltd AU:AV1	-1.106x

Annual Cash Flow Conversion Efficiency for Ok Biotech Co Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of Ok Biotech Co Ltd from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see Ok Biotech Co Ltd (4155) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$2.57 Billion ≈ $80.87 Million	NT$65.90 Million ≈ $2.08 Million	0.026x	+1996.54%
2023-12-31	NT$2.40 Billion ≈ $75.46 Million	NT$2.93 Million ≈ $92.41K	0.001x	-99.06%
2022-12-31	NT$1.85 Billion ≈ $58.17 Million	NT$240.53 Million ≈ $7.58 Million	0.130x	+913.18%
2021-12-31	NT$1.70 Billion ≈ $53.65 Million	NT$21.90 Million ≈ $689.84K	0.013x	-84.86%
2020-12-31	NT$1.74 Billion ≈ $54.79 Million	NT$147.70 Million ≈ $4.65 Million	0.085x	+144.78%
2019-12-31	NT$1.30 Billion ≈ $41.02 Million	NT$45.18 Million ≈ $1.42 Million	0.035x	-65.83%
2018-12-31	NT$1.27 Billion ≈ $39.95 Million	NT$128.75 Million ≈ $4.06 Million	0.102x	+19.16%
2017-12-31	NT$1.21 Billion ≈ $38.00 Million	NT$102.77 Million ≈ $3.24 Million	0.085x	-69.12%
2016-12-31	NT$944.80 Million ≈ $29.77 Million	NT$260.72 Million ≈ $8.21 Million	0.276x	-9.41%
2015-12-31	NT$950.15 Million ≈ $29.94 Million	NT$289.44 Million ≈ $9.12 Million	0.305x	+864.81%
2014-12-31	NT$849.48 Million ≈ $26.76 Million	NT$-33.83 Million ≈ $-1.07 Million	-0.040x	-127.88%
2013-12-31	NT$609.65 Million ≈ $19.21 Million	NT$87.08 Million ≈ $2.74 Million	0.143x	-18.43%
2012-12-31	NT$452.10 Million ≈ $14.24 Million	NT$79.17 Million ≈ $2.49 Million	0.175x	-42.99%
2011-12-31	NT$303.11 Million ≈ $9.55 Million	NT$93.12 Million ≈ $2.93 Million	0.307x	+463.30%
2010-12-31	NT$230.78 Million ≈ $7.27 Million	NT$-19.52 Million ≈ $-614.83K	-0.085x	-247.52%
2009-12-31	NT$121.25 Million ≈ $3.82 Million	NT$6.95 Million ≈ $218.96K	0.057x	--

About Ok Biotech Co Ltd

TW:4155 Taiwan Medical Devices

Market Cap

$59.00 Million

NT$1.87 Billion TWD

Market Cap Rank

#21255 Global

#1291 in Taiwan

Share Price

NT$13.00

Change (1 day)

+0.39%

52-Week Range

NT$12.90 - NT$18.15

All Time High

NT$37.98